Genpact director Tyagarajan sells $5.97 million in stock

Published 20/02/2025, 22:14
Genpact director Tyagarajan sells $5.97 million in stock

In a recent transaction, N. V. Tyagarajan, a director at Genpact Ltd (NYSE:G), sold 108,880 common shares of the company. The shares were sold at a weighted average price of $54.87, with individual sale prices ranging from $54.62 to $55.26. This transaction, which took place on February 18, 2025, amounted to a total value of approximately $5.97 million. The sale occurs as Genpact, now valued at $9.5 billion, trades near its 52-week high of $56.76, having delivered an impressive 55% return over the past year.

Following this sale, Tyagarajan holds 604,631 shares directly. Additionally, there are 5,300 shares held indirectly in a trust for the benefit of his immediate family members, with his spouse serving as one of the trustees. Tyagarajan disclaims beneficial ownership of these trust-held shares, except for his pecuniary interest. According to InvestingPro analysis, Genpact maintains a "GREAT" financial health score, with strong profitability metrics and consistent dividend payments for 9 consecutive years.

In other recent news, Genpact Ltd. has reported strong fourth-quarter earnings for 2024, exceeding consensus expectations with an earnings per share (EPS) of $0.91 and revenue of $1.25 billion. The company has also provided optimistic guidance for the first quarter of 2025, projecting an EPS of $0.79-$0.80 and revenue between $1.202 billion and $1.213 billion, surpassing market estimates. Analysts have responded positively, with TD Cowen upgrading Genpact to ’Buy’ and raising the price target to $60, while BofA Securities increased their target to $58, maintaining a ’Buy’ rating. Needham also raised its price target to $65, citing Genpact’s strong performance and strategic initiatives.

Mizuho (NYSE:MFG) Securities adjusted its price target to $55, acknowledging the company’s strong results and guidance but maintaining a Neutral rating due to concerns about its traditional Business Process Outsourcing involvement. BMO Capital Markets increased the target to $58, noting impressive execution by Genpact’s management but expressing caution about long-term growth sustainability. Genpact’s Data-Tech-AI and Digital Operations segments showed significant growth, contributing to the positive outlook. The company announced an 11% increase in its quarterly dividend and a $500 million share repurchase authorization, indicating confidence in its financial strategy.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.